| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | Dec 16, 2025 | UNITED THERAPEUTICS Corp | Director | Sell | 20.0 | -1,000 | -27.86% | ✗ | $496K |
| Mar 19, 2025 | Mar 20, 2025 | UNITED THERAPEUTICS Corp | Director | Sell | 5.0 | -5,000 | -71.43% | ✓ | $1.6M |
| Jan 10, 2025 | Jan 13, 2025 | UNITED THERAPEUTICS Corp | Director | Sell | 5.0 | -5,000 | -71.43% | ✓ | $1.8M |
| Sep 3, 2024 | Sep 5, 2024 | UNITED THERAPEUTICS Corp | Director | Sell | 17.5 | -5,000 | -63.29% | ✗ | $1.8M |
| Jun 17, 2024 | Jun 18, 2024 | UNITED THERAPEUTICS Corp | Director | Sell | 20.0 | -2,000 | -64.52% | ✗ | $591K |
| May 14, 2024 | May 15, 2024 | UNITED THERAPEUTICS Corp | Director | Sell | 20.0 | -1,310 | -54.36% | ✗ | $346.3K |
| Feb 23, 2024 | Feb 26, 2024 | UNITED THERAPEUTICS Corp | Director | Sell | 20.0 | -1,680 | -60.34% | ✗ | $376.3K |
| Nov 7, 2023 | Nov 8, 2023 | UNITED THERAPEUTICS Corp | Director | Sell | 20.0 | -2,000 | -41.81% | ✗ | $460.9K |
| Aug 17, 2023 | Aug 18, 2023 | UNITED THERAPEUTICS Corp | Director | Sell | 7.5 | -2,000 | -41.81% | ✓ | $456.2K |
| May 10, 2023 | May 11, 2023 | UNITED THERAPEUTICS Corp | Director | Sell | 7.5 | -2,000 | -41.81% | ✓ | $424.5K |
| Jul 17, 2017 | May 3, 2023 | UNITED THERAPEUTICS Corp | Director | Buy | 55.0 | +4 | 0.14% | ✗ | $529.2 |
| Mar 15, 2023 | Mar 16, 2023 | UNITED THERAPEUTICS Corp | Director | Sell | 7.5 | -2,000 | -41.84% | ✓ | $435K |
| Jan 3, 2023 | Jan 4, 2023 | UNITED THERAPEUTICS Corp | Director | Sell | 7.5 | -2,000 | -41.84% | ✓ | $546.6K |
| Nov 16, 2022 | Nov 18, 2022 | UNITED THERAPEUTICS Corp | Director | Sell | 7.5 | -1,600 | -36.53% | ✓ | $417.8K |
| Aug 17, 2022 | Aug 18, 2022 | UNITED THERAPEUTICS Corp | Director | Sell | 7.5 | -3,000 | -39.68% | ✓ | $664.9K |
| May 17, 2022 | May 18, 2022 | UNITED THERAPEUTICS Corp | Director | Sell | 7.5 | -2,000 | -40.98% | ✓ | $382K |
| Apr 7, 2022 | Apr 8, 2022 | UNITED THERAPEUTICS Corp | Director | Sell | 7.5 | -2,000 | -40.98% | ✓ | $380.2K |
| Mar 15, 2022 | Mar 16, 2022 | UNITED THERAPEUTICS Corp | Director | Sell | 20.0 | -2,000 | -40.98% | ✗ | $357.6K |
| Nov 11, 2021 | Nov 12, 2021 | UNITED THERAPEUTICS Corp | Director | Sell | 7.5 | -2,000 | -40.98% | ✓ | $401.8K |
| Nov 8, 2021 | Nov 8, 2021 | UNITED THERAPEUTICS Corp | Director | Sell | 20.0 | -2,300 | -44.40% | ✗ | $460.4K |
| Aug 4, 2021 | Aug 6, 2021 | UNITED THERAPEUTICS Corp | Director | Sell | 7.5 | -2,000 | -27.86% | ✓ | $412.2K |
| May 6, 2021 | May 10, 2021 | UNITED THERAPEUTICS Corp | Director | Sell | 7.5 | -2,600 | -42.62% | ✓ | $499.2K |
| Dec 8, 2020 | Dec 9, 2020 | UNITED THERAPEUTICS Corp | Director | Sell | 7.5 | -3,000 | -45.45% | ✓ | $405.2K |
| Aug 5, 2020 | Aug 6, 2020 | UNITED THERAPEUTICS Corp | Director | Sell | 7.5 | -5,000 | -58.14% | ✓ | $565.4K |
| Mar 17, 2020 | Mar 18, 2020 | UNITED THERAPEUTICS Corp | Director | Sell | 7.5 | -5,000 | -79.37% | ✓ | $402.8K |